|
|
Rositta Buracas, one of the Canadian women who take Premarin, was shocked to see that her three-month bill went from about $25, including dispensing fee, to more than $125. |
Users of Premarin drug stunned by price hike
Updated Wed. Jun. 3 2009 10:50 PM ET
CTV.ca News Staff
Women who take the hormone replacement therapy drug Premarin are getting a big case of sticker shock when they renew their prescriptions these days.
That's because as of April 1, a month's supply of the medication has risen an astonishing 800 per cent, from about 14 cents a pill to about $1.24 a pill.
The price hike isn't due to any changes in the drug's formulation or packaging; it's simply a matter of supply and demand, says its manufacturer, Wyeth Canada.
With a number of studies linking long-term hormone replacement use to increased risks of breast cancer, many women have gone off the drug. But some women who have debilitating menopause symptoms weighed the risks along with their doctor and decided to take hormone replacement medications.
But the drop-in demand has left Wyeth with few options but to raise prices, it says.
"Wyeth Canada is increasing the price of Premarin to more appropriately reflect the costs and value of the product today," the company said in an email to CTV News.
"The new price is reflective of current costs, including higher manufacturing and ingredient costs and a long-term, steady reduction in the consumption of the product, increasing the per-dose and per-patient cost significantly.
"We believe this adjustment is fair and reasonable and it reflects the tremendous value of Premarin to Canadian women, while remaining competitive to other products in its category," the company said, noting that the current price remains below the average cost of prescriptions in Canada.
Rositta Buracas is one of the Canadian women who take Premarin. She says it helps her sleep better, feel better, and ward off osteoporosis. When she noticed the price increase last month, she was shocked. Her three-month bill went from about $25 -- including dispensing fee -- to more than $125. Prices vary slightly depending on pharmacy.
"When they showed me the bill I said, 'You've got to be joking, right?'"
A reader of the CTV MedNews Express health blog wrote in to say that she, too, was stunned with the price hike.
"I'm very upset at the company," Emily told CTV. "Companies shouldn't do this to their patients."
There is no generic version of Premarin, meaning there are no easy alternatives for patients. While generic conjugated estrogen can be used instead, many may find that the price is not much lower than Premarin.
Premarin's pricing based on market demand
There is little the federal government can do. That's because Premarin is no longer a patented medication, its pricing doesn't come under the jurisdiction of the federal government's Patented Medicine Review Board and companies are free to set pricing based on market demand.
Rositta has her own demand and that's that women write in to Wyeth and demand a more reasonable price increase.
"I want the company to sit up and take notice. They'd better do something because there will be lots of bitchy hormonal women out there!" she says.
Dr. Jim Wright of the University of British Columbia's Therapeutics Initiative, which analyzes prescription medication independently of pharmaceutical companies, says when there are no patents, companies can price a drug at whatever the market can handle.
He says at its new price, Premarin is not good value. He says women should reconsider whether they should talk with their doctors and assess whether they'd be better off with another kind of estrogen medication.
"I would also recommend all provincial drug plans, when they become aware of this, to no longer fund it, and private insurance should not fund it because it's not good value," he says.
Wyeth Pharmaceuticals says its decision "was based on extensive research, including discussions with stakeholders, physicians and patients, and reflects the value Premarin brings to Canadian women. Key inputs from that research showed that Canadian physicians and women wanted us to continue to offer the product."
"While we understand this is undesirable for some patients, the only other option was to remove the product from the market, and many Canadian women continue to rely on this unique product."
The company says that if women can't afford it, their doctors can apply for it on compassionate release and get a 100-day supply for free, while patients "consider options for payment or transitioning to an alternate product."
With a report from CTV medical specialist Avis Favaro and producer Elizabeth St. Philip
Comments are now closed for this story
| Gerry |
|
0 |
| 0 |
|
Another case of large Pharmaceutical gouging the consumer, especially those that can not afford it. 100 days of free pills will not appease those in need if they have to beg their doctor to plead their case every 100 days. This sounds like a case for a facebook campaign to bring this company to it's knees and lower its prices. |
| Matt |
|
0 |
| 0 |
|
Force them to sell at a loss, and they simply won't make the drug. Don't like it, don't use the drug. You have to realize, although other drug companies can legally make this drug, they don't want to either. These women are lucky they didn't just stop making the drug because it wasn't profitable. Maybe they should have never made it so cheap to begin with, many other drugs are more than $1/pill. They'd have more money and nobody would be complaining. |
| Jay-TO |
|
0 |
| 0 |
|
"...its decision "was based on extensive research, including discussions with stakeholders, physicians and patients, and reflects the value Premarin brings to Canadian women." Typical business people mumbo jumbo. What they mean to say is we can make the same amount of money selling to rich people so screw the rest. This occurs in every indiustry., especially the new "green" industries where only rich can afford organics and alternative fuel. Capitalism is horrible in the way it treats those who are NOT stinking rich. It kills people while allowing others to wallow in their greed. |
| THE Fatman |
|
0 |
| 0 |
|
Methinks there's something rotten in Denmark here ... Always thought that with a drop in demand for a product there should be drop in that product's price as the commodity availability level rises, assuming production levels for that commodity remain constant. Conversely, with an increase in demand for a product there should be a corresponding increase in its price as that commodity availability level drops, again assuming a constant production level for the commodity in question. And oh, by the way, will somebody please tell me is 'gouging' really spelled G-O-U-G-I-N-G? (And why am I not surprised a drug company seems to be at the root of this?) |
| Ron J. - Calgary |
|
0 |
| 0 |
|
A drop in demand, and the price of this drug goes up. Yet when the demand for gasoline increases, like during the summer or on a long weekend, there is an increase in price. Cake and eat it too. It seems prices go up for products whether the demand is up or down. Must be nice. |
| Leslie |
|
0 |
| 0 |
|
I’m glad that the price on Premarin has gone up. The drug is made with horse urine. If women taking it knew how much suffering it causes horses I think they would think again. |
| DANIEL H |
|
0 |
| 0 |
|
Supply and demand rules the economy we live in. Don't complain about $125 every three months. There are lots of us out there with bigger expenses. My wife and I spent over $30,000 last year. |
Subscribe!
CTV.ca Blogs
Video
Related Stories
Web Links
User Tools
Health Stories
- Democrats push U.S. health-care bill past Senate hurdle
- Weight gain guide for pregnant Canadians revised
- Batch of H1N1 vaccine pulled after bad reactions
- U.S. guidelines call for fewer Pap tests for women
- As cost of child vaccines fall, more kids are saved
- American military tries to predict post-traumatic stress
- Health spending to hit $183B this year, up $10B from '08
- Canada warns vets and pet owners about drug
- RCMP, CBSA join effort to eradicate fake drug trade
- H1N1 riskier for kids with asthma than regular flu
- One conjoined twin talking after separation surgery
- H1N1 vaccine didn't kill 41 people: WHO



